Cevidoplenib dimesylate

Overview

Cevidoplenib is an orally available inhibitor of spleen tyrosine kinase ( Syk ) , with potential anti-inflammatory and immunomodulating activities.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Rheumatoid Arthritis | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Syk

Product Information

• Catalog No.: HY-109082A
• CAS No.: 2043659-93-2
• Molecular Formula: C27H35N7O9S2
• Molecular Weight: 665.74
• Purity: 98.96%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (3.76 mM); Clear solution
• Availability: In-stock

Source

Original product source